Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-63.33%
0%
-63.33%
6 Months
-67.65%
0%
-67.65%
1 Year
-71.79%
0%
-71.79%
2 Years
-60.71%
0%
-60.71%
3 Years
-77.08%
0%
-77.08%
4 Years
-85.33%
0%
-85.33%
5 Years
-42.11%
0%
-42.11%
Ananda Developments Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.20%
EBIT Growth (5y)
-226.74%
EBIT to Interest (avg)
-1.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
11.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.66
EV to EBIT
-2.90
EV to EBITDA
-3.53
EV to Capital Employed
10.37
EV to Sales
10.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-357.10%
ROE (Latest)
-172.13%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Jan'24
Jan'24
Jan'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.20
-0.90
77.78%
Interest
0.00
0.20
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.20
-1.10
81.82%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Jan 2024 is 0.00% vs 0.00% in Jan 2023
Consolidated Net Profit
YoY Growth in year ended Jan 2024 is 81.82% vs -10.00% in Jan 2023
About Ananda Developments Plc 
Ananda Developments Plc
Capital Markets
Ananda Developments Plc is a United Kingdom-based investment company. The Company provides a United Kingdom-based listed platform for cannabis investors. The Company focuses its investments in the medicinal or therapeutic Cannabis derivatives, or related products, including nutraceuticals, dietary supplements and cosmetic products, which contain Cannabis or hemp-derived cannabinoids.
Company Coordinates 
Company Details
6th Fl, Allianz House, 60 Gracechurch Street LONDON None : EC3V 0HR
Registrar Details






